Cellectar Biosciences, Inc. Accounts Payable
Cellectar Biosciences, Inc. (CLRB) had Accounts Payable of $1.44 million as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-03-04
- 2025-12-31: Accounts Payable, Current $1.44M.
- 2024-12-31: Accounts Payable, Current $4.11M.
- 2023-12-31: Accounts Payable, Current $5.62M.
- 2022-12-31: Accounts Payable, Current $2.56M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-12-31 | $1.44M 10-K · filed 2026-03-04 |
| 2024-12-31 | $4.11M 10-K · filed 2026-03-04 |
| 2023-12-31 | $5.62M 10-K · filed 2025-03-13 |
| 2022-12-31 | $2.56M 10-K/A · filed 2024-10-29 |
| 2021-12-31 | $1.42M 10-K · filed 2023-03-09 |
| 2020-12-31 | $1.43M 10-K · filed 2022-03-21 |
| 2019-12-31 | $1.28M 10-K · filed 2021-03-02 |
| 2018-12-31 | $612.00K 10-K · filed 2020-03-09 |
| 2017-12-31 | $933.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |